Kyverna Therapeutics (KYTX)'s 30-day implied volatility (IV30) was 62.1% at the close on November 2, 2026, down from 74.2% the day before, against a 52-week range of 58.4% to 107.2%. Its 20-day historical volatility was 64.8%.
Data as of November 2, 2026.